188 related articles for article (PubMed ID: 23577424)
1. Economic considerations in managing patients with chronic stable angina.
Nutescu EA
J Manag Care Pharm; 2006 Oct; 12(8 Suppl):S17-21. PubMed ID: 23577424
[TBL] [Abstract][Full Text] [Related]
2. Annual cost of stable coronary artery disease in France: A modeling study.
Caruba T; Chevreul K; Zarca K; Cadier B; Juillière Y; Dubourg O; Sabatier B; Danchin N
Arch Cardiovasc Dis; 2015 Nov; 108(11):576-88. PubMed ID: 26433733
[TBL] [Abstract][Full Text] [Related]
3. Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice.
Osnabrugge RL; Head SJ; Bogers AJ; Kappetein AP
Expert Rev Cardiovasc Ther; 2013 Jul; 11(7):903-18. PubMed ID: 23895033
[TBL] [Abstract][Full Text] [Related]
4. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
[TBL] [Abstract][Full Text] [Related]
5. Economic Analysis of Surgical and Interventional Treatments for Patients with Complex Coronary Artery Disease: Insights from a One-Year Single-Center Study.
Zhao Y; Meng S; Liu T; Dong R
Med Sci Monit; 2020 Feb; 26():e919374. PubMed ID: 32097388
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous revascularization improves outcomes in patients with prior coronary artery bypass surgery.
Gyenes G; Norris CM; Graham MM;
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E148-54. PubMed ID: 23208677
[TBL] [Abstract][Full Text] [Related]
8. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
Eisenstein EL; Leon MB; Kandzari DE; Mauri L; Edwards R; Kong DF; Cowper PA; Anstrom KJ;
JACC Cardiovasc Interv; 2009 Dec; 2(12):1199-207. PubMed ID: 20129546
[TBL] [Abstract][Full Text] [Related]
10. Review of recent US cost estimates of revascularization.
Nagle PC; Smith AW
Am J Manag Care; 2004 Oct; 10(11 Suppl):S370-6. PubMed ID: 15603246
[TBL] [Abstract][Full Text] [Related]
11. Optimal medical therapy and percutaneous coronary intervention for stable angina: why patients should 'be taking' and 'keep taking' the tablets.
Mohee K; Wheatcroft SB
J Clin Pharm Ther; 2014 Aug; 39(4):331-3. PubMed ID: 24754310
[TBL] [Abstract][Full Text] [Related]
12. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
[TBL] [Abstract][Full Text] [Related]
14. Revascularization versus medical treatments in stable coronary artery disease: predicting the future of novel drug therapies for stable angina.
Risos L; Berkenboom G
J Cardiovasc Pharmacol; 2014 Mar; 63(3):213-7. PubMed ID: 24336013
[TBL] [Abstract][Full Text] [Related]
15. Surgical myocardial revascularization versus percutaneous coronary intervention with drug-eluting stents in octogenarian patients.
Ben-Gal Y; Finkelstein A; Banai S; Medalion B; Weisz G; Genereux P; Moshe S; Pevni D; Aviram G; Uretzky G
Heart Surg Forum; 2012 Aug; 15(4):E204-9. PubMed ID: 22917825
[TBL] [Abstract][Full Text] [Related]
16. Comparative one-year effectiveness of percutaneous coronary intervention versus coronary artery bypass grafting in patients <75 versus ≥75 years with unprotected left main disease (from the CUSTOMIZE Registry).
Capodanno D; Caggegi A; Capranzano P; Milino V; Chisari A; Mangiameli A; Monaco S; Barrano G; Di Salvo ME; Tamburino C
Am J Cardiol; 2012 Nov; 110(10):1452-8. PubMed ID: 22853983
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve.
Fearon WF; Shilane D; Pijls NH; Boothroyd DB; Tonino PA; Barbato E; Jüni P; De Bruyne B; Hlatky MA;
Circulation; 2013 Sep; 128(12):1335-40. PubMed ID: 23946263
[TBL] [Abstract][Full Text] [Related]
18. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease.
Gössl M; Faxon DP; Bell MR; Holmes DR; Gersh BJ
Circ Cardiovasc Interv; 2012 Aug; 5(4):597-604. PubMed ID: 22896575
[No Abstract] [Full Text] [Related]
19. Establishing the cost-effectiveness of percutaneous coronary intervention for chronic total occlusion in stable angina: a decision-analytic model.
Gada H; Whitlow PL; Marwick TH
Heart; 2012 Dec; 98(24):1790-7. PubMed ID: 23038791
[TBL] [Abstract][Full Text] [Related]
20. Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study.
Favarato D; Hueb W; Gersh BJ; Soares PR; Cesar LA; da Luz PL; Oliveira SA; Ramires JA;
Circulation; 2003 Sep; 108 Suppl 1():II21-3. PubMed ID: 12970202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
